Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

92.72 -0.45 (-0.48%)
Streaming Delayed Price Updated: 2:35 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript
AXSM earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
A Closer Look at 10 Analyst Recommendations For Axsome Therapeutics
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market. 
Via The Motley Fool
Breaking Down Axsome Therapeutics: 19 Analysts Share Their Views
Via Benzinga
1 Under-the-Radar Biotech Stock to Buy and Hold
It could be an industry giant in the making. 
Via The Motley Fool
What Analysts Are Saying About Axsome Therapeutics Stock
Via Benzinga
Unveiling 14 Analyst Insights On Axsome Therapeutics
Via Benzinga
A Glimpse Into The Expert Outlook On Axsome Therapeutics Through 9 Analysts
Via Benzinga
Decoding 9 Analyst Evaluations For Axsome Therapeutics
Via Benzinga
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript
AXSM earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Axsome Therapeutics Stock Is Sinking Today
Investors were unhappy with Axsome's worse-than-expected Q2 loss. 
Via The Motley Fool
Axsome Plunges On Wide Losses, But Its Biggest Moneymaker Tacks On 135% Growth
The company makes treatments for depression and excessive daytime sleepiness. 
Via Investor's Business Daily
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
Jim Cramer discusses Torm, Trane, Sap and Axsome Therapeutics on CNBC's "Mad Money Lightning Round." 
Via Benzinga
Should You Buy This Sinking Stock on the Dip?
The biotech isn't having the best year. 
Via The Motley Fool
15 Analysts Assess Axsome Therapeutics: What You Need To Know
Via Benzinga
7 Biotech Stocks to Keep on Your Clinical Radar
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. 
Via InvestorPlace
Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
Needham initiated coverage on Axsome Therapeutics, highlighting its diverse CNS portfolio. The analyst predicts an 8-10x risk-adjusted topline growth in five years, driven by marketed drugs Auvelity... 
Via Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
These innovative drugmakers are hard to ignore. 
Via The Motley Fool
The 3 Best Biotech Stocks to Buy in July 2024
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024. 
Via InvestorPlace
3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise. 
Via InvestorPlace
Why Axsome Therapeutics Stock Is Sinking Today
A short-seller report is causing a sell-off of the biotech stock. 
Via The Motley Fool
Hello Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
3 Monster Stocks in the Making You Can Buy Right Now
These stocks might not be small for too much longer. 
Via The Motley Fool
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
Three most undervalued biotech stocks to buy now will take off in the coming years and bring back continuous, hefty returns. 
Via InvestorPlace
Prediction: These 2 Growth Stocks Could Triple By 2030
These companies have a habit of silencing the bears. 
Via The Motley Fool
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
AXSM earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
AXSM Stock Earnings: Axsome Therapeutics Beats EPS, Beats Revenue for Q1 2024
AXSM stock results show that Axsome Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS